APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
64 hedge funds and large institutions have $277M invested in Aptose Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
22% more capital invested
Capital invested by funds: $227M → $277M (+$50.7M)
10% more funds holding
Funds holding: 58 → 64 (+6)
Holders
64
Holding in Top 10
5
Calls
$1.55M
Puts
$135K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$7.39M | |
| 3 | +$5.75M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.72M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$5.68M |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$4.73M | |
| 3 | -$687K | |
| 4 |
Renaissance Technologies
New York
|
-$656K |
| 5 |
Two Sigma Investments
New York
|
-$353K |